Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Study finds genetic link to acute myeloid leukaemia

04 April 2011

By Maren Urner

Appeared in BioNews 602

Researchers from the Wellcome Trust Sanger Institute have identified three different genetic mutations linked to acute myeloid leukaemia (AML), a cancer that is characterised by a rapid increase in abnormal white blood cells in the bone marrow.

Leading scientist, Dr George Vassiliou and his team activated the human version of the gene NPM1 in mice, the most common gene associated with the cancer, and demonstrated that this led to an increased ability of the cells to renew themselves, a boosted formation of myeloid cells and the over-expression of the gene - all signs of the cancer. However, although the NPM1 mutation could be seen to kick-start the leukaemic process, only three out of ten mice developed leukaemia suggesting it was not solely responsible for the development of the disease.

The researchers then ran a second set of experiments to generate mutations in other genes in the mice and identified two additional types of mutations causing AML - one of which affects cell division and growth, while the other alters a cell's environment.

'In concert, these genetic mutations, which were concentrated on a tiny number of genes, transformed normal to leukaemic cells', said co-author of the study Professor Allan Bradley, a former Director of the Wellcome Trust Sanger Institute and who was involved in the study.

Dr David Grant, scientific director at the charity Leukaemia and Lymphoma Research, summarised the significance of the study, saying 'it offers an invaluable insight into the role of the most common form of mutation found in acute myeloid leukaemia'. He added: 'It explains how it develops and the other genetic factors that drive the leukaemia's growth'.

Around two thousand adults in the UK are diagnosed with AML each year and it is the second most common leukaemia in children. It is more aggressive and progresses more quickly than other forms of leukaemia but with treatment over half of all patients under the age of 60 are cured. Dr Grant said the study 'offers a potential model for the development of new drugs for this terrible disease in the future'.

The study was published in Nature Genetics.

SOURCES & REFERENCES
BBC News Health | 27 March 2011
 
Nature Genetics | 27 March 2011
 
Genetic Engineering and Biotechnology News | 28 March 2011
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

01 December 2014 - by Dr Anna Cauldwell 
Genetics researchers in the US have identified mutations that significantly increase the likelihood that an individual will go on to develop blood cancer...
15 April 2013 - by Dr Katie Howe 
Genome analysis of identical twins with childhood leukaemia has helped pinpoint genetic mutations which may kick-start the disease in the mother's womb...
25 March 2013 - by John Brinsley 
Early results of an experimental gene therapy against an aggressive form of leukaemia have been hailed by researchers as showing 'life saving potential'....
05 December 2011 - by Dr Zara Mahmoud 
Two new gene variants, which each increase the risk of bone marrow cancer by 30 percent, have been identified by scientists at the Institute for Cancer Research...
03 May 2011 - by Mehmet Fidanboylu 
Two US studies have demonstrated how whole-genome screening can help improve cancer treatment and diagnosis. The researchers claim to have taken a major step towards using this type of screening to help predict patients' responses to different treatments based on their genetics...

01 September 2009 - by Lorna Stewart 
Research published earlier this month in Nature Genetics is the first to show that there is a genetic component to acute lymphoblastic leukaemia (ALL), the most common form of childhood cancer.
10 August 2009 - by Adam Fletcher 
The second complete cancer cell genome sequence was published online last week in the New England Journal of Medicine, representing a pioneering effort to comprehensively describe the hundreds of genetic changes that underlie this most insidious of diseases...
12 January 2009 - by Dr Charlotte Maden 
A new report published online in the New England Journal of Medicine last week describes the clinical relevance of the genetic changes in children with acute lymphoblastic leukaemia (ALL). ALL, a cancer of the blood and bone marrow, is the most prevalent cancer in children. The cure...
01 December 2008 - by Dr Charlotte Maden 
Scientists have uncovered key genetic changes in the cancer-causing cells when childhood leukaemia recurs. It is hoped that the findings can be used to help beat the disease. Acute lymphoblastic leukaemia (ALL), a cancer of the blood and bone marrow, is the most common form of childhood...
17 October 2003 - by BioNews 
US and European scientists have published results confirming that a gene therapy technique triggered leukaemia in two boys taking part in a trial at the Necker hospital, Paris. Their findings, which appear in Science, show that the virus used to deliver the therapeutic gene activated a cancer-causing gene. Eleven boys...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation